Britain could get the Pfizer vaccine to the Americans first as regulators prepare for a quick decision and the NHS prepares its staff for a roll-out on 1 December.
The UK’s watchdog will soon be in the US. Drugs Giant Pfizer Inc. And German biotech company Byntech S.E. The Covid-19 produced by will open its formal formal evaluation.
A government source told The Telegraph last night that in the ‘best case season’, the regulator would green the vaccine in less than a week and asked the NHS to prepare for the vaccine by early next month.
Meanwhile, U.S. The regulator, the Food and Drug Administration (FDA), is not scheduled to meet until December 10 – but it could give its verdict in less than 24 hours.
The head of Donald Trump’s Operation Operations, Dr. Monsef Sloi, said yesterday that inoculations could begin “a day or two after approval on the 11th or 12th.”
British Prime Minister Boris Johnson speaks during a virtual press conference inside 10 Downing Street in central London on October 20, 2020.
The British government insisted that the regulatory process undertaken by the Medicines and Healthcare Products Regulatory Agency (MHRA) was independent and would take as long as necessary.
A spokesman said last night that “an extensive plan has been put in place to ensure that our health service is ready to bring in the Covid-19 vaccine.”
MHRA, an executive agency of the health department, was asked last week to evaluate the suitability of the Pfizer-Bioentech vaccine.
Britain has ordered 40 million doses and expects 10 million doses, enough to protect 5 million people, to be available by the end of the year if regulators approve it.
Matt Hancock has said he is “increasingly confident” that spring will bring life closer to normal.
The health secretary said last week: ‘If the regulator approves the vaccine, we will be ready to launch the vaccine next month with a bulk roll-out in the new year.
“We are moving in the right direction, but there is still a long way to go.”
Mr Hancock emphasized the independence of the MHRA and said he did not want to “imprint their independence”.
Asked what assurances he was given by the regulator about how long it would take for the process to take place, he said: “It’s just a question of how long it takes for them, I’m not going to pre-judge about that.”
Donald Trump at the White House earlier this month
Professor Jonathan Van-Tut, the Deputy Chief Medical Officer of England, said the assessment would be “done at the speed of science and we need to leave it at that and believe in it to move forward”.
If approved, the elderly would be the first to receive care in care homes and care home workers, as advised by the Joint Committee on Vaccination and Immunization.
This will then be followed by those aged 80 and over, and by health and social care workers.
NHS documents leaked by the Health Service Journal (HSJ) leaked, suggesting that all adults in England – any age – should be vaccinated against Covid-19 before the end of January if they are allowed to supply.
Under the scheme, every adult who needs it will be vaccinated in early April, HSJ said.
Mr Hancock said the military and the NHS have been on standby to bring the vaccine to the UK since early December, and would work “seven days a week” to do so.
He is a care home, G.P. And will be delivered by ‘go-to’ vaccination centers set up at places such as pharmacists, as well as sports halls.
The health secretary said the UK would be among the first countries in the world to be able to do this.
As well as its 40 million dose agreement for the Pfizer vaccine, the government has secured a ‘preliminary agreement’ for 5 million doses of the Moderna vaccine and another 100 million doses of Ox Xford Jab.
All vaccines undergo rigorous testing and are supervised by experienced regulators.
Moderna said its available safety data does not indicate any significant security concerns.
Their tests found that the vaccine was generally safe and well tolerated, and most adverse events were mild or severe.
The Pfizer Jab is known as the Messenger RNA (MRNA) vaccine.
Conventional vaccines are made using weaker forms of the virus, but mRNAs only use the genetic code of the virus.
They work by telling the body’s cells to make antigens, which are identified by the immune system and prepare it to fight the coronavirus.
Coronavirus vaccine vials found in promotional photographs for Pfizer
Some believe that mRNA vaccines are safe for the patient because they do not rely on any of the components injected into the body of the virus.
The Pfizer vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised.
With the Oxford / AstraZeneca vaccine – known as CHAdOx1 nCov-2019 – no serious adverse reactions to the trial were observed in the trial participants.
More than 200 coronavirus vaccine candidates are being investigated worldwide.
About 12 of them are in the final stages of testing, but Pfizer is the first to report any results.
Other potential vaccines in the phase three trial include biotech company NovavX.
.
